Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference5 articles.
1. Tissue distribution of phosphodiesterase families and the effect of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro;Wallis;Am J Cardiol,1999
2. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension;Michelakis;Circulation,2002
3. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension;Ghofrani;Ann Intern Med,2002
4. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomized controlled trial;Ghofrani;Lancet,2002
5. Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension;Chinose;Crit Care Med,2001
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function;European Journal of Heart Failure;2024-04
2. Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure;Children;2023-01-31
3. Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors;Pharmaceuticals;2022-08-19
4. Challenges in pulmonary hypertension associated with left heart disease;Expert Review of Cardiovascular Therapy;2019-06-03
5. Preimplant Phosphodiesterase-5 Inhibitor Use Is Associated With Higher Rates of Severe Early Right Heart Failure After Left Ventricular Assist Device Implantation;Circulation: Heart Failure;2019-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3